Tevogen Bio Says Its Internally Developed Intellectual Property And Product Assets, Valued Internally At $10B+ Using Discounted Cash Flow Models, Are Not Reflected On Balance Sheet
Tevogen Bio Says Its Internally Developed Intellectual Property And Product Assets, Valued Internally At $10B+ Using Discounted Cash Flow Models, Are Not Reflected On Balance Sheet
Tevogen Bio表示，其內部開發的知識產權和產品資產，使用貼現現金流模型內部評估價值超過100億美元，但未在資產負債表上反映。
Tevogen Bio Says Its Internally Developed Intellectual Property And Product Assets, Valued Internally At $10B+ Using Discounted Cash Flow Models, Are Not Reflected On Balance Sheet
Tevogen Bio 表示，其內部開發的知識產權和產品資產，使用折現現金流模型內部估值超過100億美元，未在資產負債表上反映。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間